BRISTOL MYERS SQUIBB CO - 8-K Filing
Bristol-Myers Squibb reports Q2 revenue growth to $13.0 billion and raises full-year guidance (Items: 2.02 Results of Operations and Financial Condition, 7.01 Regulation FD Disclosure, 9.01 Financial Statements and Exhibits)
Tickers: $BMY